173 related articles for article (PubMed ID: 16979977)
1. Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection.
Cao G; Lu Y; Gao R; Xin Y; Teng D; Wang J; Li Y
Transplant Proc; 2006 Sep; 38(7):1998-2000. PubMed ID: 16979977
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
Rintala SE; Savikko J; Rintala JM; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor in chronic rat allograft nephropathy.
Malmström NK; Kallio EA; Rintala JM; Nykänen AI; Räisänen-Sokolowski AK; Paavonen T; Lemström KB; Koskinen PK
Transpl Immunol; 2008 May; 19(2):136-44. PubMed ID: 18503889
[TBL] [Abstract][Full Text] [Related]
5. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
6. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine expression in human renal inflammation.
Cockwell P; Chakravorty SJ; Girdlestone J; Savage CO
J Pathol; 2002 Jan; 196(1):85-90. PubMed ID: 11748646
[TBL] [Abstract][Full Text] [Related]
8. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.
Choi YJ; Chakraborty S; Nguyen V; Nguyen C; Kim BK; Shim SI; Suki WN; Truong LD
Hum Pathol; 2000 Dec; 31(12):1491-7. PubMed ID: 11150374
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
[TBL] [Abstract][Full Text] [Related]
10. Impact of chemokine receptor CX3CR1 in human renal allograft rejection.
Hoffmann U; Bergler T; Segerer S; Rümmele P; Krüger B; Banas MC; Reinhold S; Banas B; Krämer BK
Transpl Immunol; 2010 Aug; 23(4):204-8. PubMed ID: 20600902
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.
Reinders ME; Fang JC; Wong W; Ganz P; Briscoe DM
Transplantation; 2003 Jul; 76(1):224-30. PubMed ID: 12865814
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression and vascularity in renal allograft biopsies.
Sarioğlu S; Celik A; Erşen A; Uçer I; Sağlam F; Camsari T; Gülay H
Transplant Proc; 2008; 40(1):178-80. PubMed ID: 18261579
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cyclosporine versus mycophenolate mofetil on expression of Fractalkine and CX3CR1 in chronic allograft nephropathy.
Cao G; Lu Y; Gao R; Xin Y; Teng D; Wang J; Wang L; Li Y
Transplant Proc; 2006 Sep; 38(7):2234-6. PubMed ID: 16980051
[TBL] [Abstract][Full Text] [Related]
14. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
[TBL] [Abstract][Full Text] [Related]
15. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
[TBL] [Abstract][Full Text] [Related]
18. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
[TBL] [Abstract][Full Text] [Related]
19. Role of peritubular capillaries and vascular endothelial growth factor in chronic allograft nephropathy.
Modelli de Andrade LG; Viero RM; Carvalho MF
Transplant Proc; 2009 Nov; 41(9):3720-5. PubMed ID: 19917374
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression in human chronic renal allograft rejection.
Pilmore HL; Eris JM; Painter DM; Bishop GA; McCaughan GW
Transplantation; 1999 Mar; 67(6):929-33. PubMed ID: 10199746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
